Kinane D F, Darby I B, Said S, Luoto H, Sorsa T, Tikanoja S, Mäntylä P
University of Louisville School of Dentistry, Kentucky, USA.
J Periodontal Res. 2003 Aug;38(4):400-4. doi: 10.1034/j.1600-0765.2003.00663.x.
The aim of this study was to investigate the effect of scaling and root planing (SRP) and the maintenance phase of treatment on the gingival crevicular fluid (GCF) matrix metalloproteinase-8 (MMP-8) levels.
Clinical measurements and GCF samples were taken from four sites in 20 adult periodontitis patients before and after SRP and during a 3-month maintenance phase of treatment. MMP-8 levels were measured from GCF samples by time-resolved immunofluorometric assay (IFMA) with monoclonal antibodies.
SRP improved the clinical indices as would be predicted, 6.1 mm (SD = 1.4) at baseline compared with 4.3 mm (SD = 1.6) post-treatment (P < 0.001). Attachment level (AL) reduced but not significantly between these two visits 13.4 mm (SD = 2.4) compared with 12.8 mm (SD = 2.4) (P < 0.08) post therapy. GCF MMP-8 levels reduced after initial treatment from 33.8 micro g/30 s sample to 23.5 micro g/30 s, which just failed to reach statistical significance (P = 0.07). However, when MMP-8 levels were expressed as a concentration, the differences following initial therapy were significant (54.1 ng/ micro L at baseline compared with 34.2 ng/micro L post treatment; P < 0.005). The difference, however, between the baseline MMP-8 levels (33.8 ng/30 s) and the final visit (16 ng/30 s) following maintenance was markedly significant (P < 0.001) for both absolute amounts and on a concentration basis.
In conclusion, clinical improvement following SRP was associated with significant reductions in MMP-8 levels. The GCF concentration of MMP-8 decreased after initial therapy but reduced even more dramatically (approximately 50%) following a 3-month period of maintenance (P < 0.001).
本研究旨在调查龈下刮治术(SRP)及治疗维护阶段对龈沟液(GCF)中基质金属蛋白酶-8(MMP-8)水平的影响。
从20名成人牙周炎患者的四个位点采集临床测量数据及GCF样本,分别在SRP治疗前后以及为期3个月的治疗维护阶段进行采集。采用单克隆抗体通过时间分辨免疫荧光分析法(IFMA)测量GCF样本中的MMP-8水平。
如预期的那样,SRP改善了临床指标,基线时为6.1mm(标准差=1.4),治疗后为4.3mm(标准差=1.6)(P<0.001)。两次就诊之间附着水平(AL)有所降低,但不显著,治疗前为13.4mm(标准差=2.4),治疗后为12.8mm(标准差=2.4)(P<0.08)。初始治疗后GCF中MMP-8水平从33.8μg/30s样本降至23.5μg/30s,仅未达到统计学显著性(P=0.07)。然而,当将MMP-8水平表示为浓度时,初始治疗后的差异具有显著性(基线时为54.1ng/μL,治疗后为34.2ng/μL;P<0.005)。不过,对于绝对量和浓度而言,基线MMP-8水平(33.8ng/30s)与维护期最后一次就诊时(16ng/30s)之间的差异均极为显著(P<0.001)。
总之,SRP后的临床改善与MMP-8水平的显著降低相关。初始治疗后MMP-8的GCF浓度降低,但在为期3个月的维护期后降低得更为显著(约50%)(P<0.001)。